Search research articles
Contact Us
Filters
Showing results (151-160 of 167) with videos related to
Page
of 17
Sort By:
Clinical Pharmacology and Therapeutics
|
April 1, 1983
Effects of desmethylimipramine on plasma norepinephrine, pulse, and blood pressure
R J Ross, A P Zavadil, H M Calil, et al.
Archives of General Psychiatry
|
July 1, 1990
Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia
D Pickar, A Breier, J K Hsiao, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1986
Treatment of childhood hyperactivity with desipramine: plasma drug concentration, cardiovascular effects, plasma and urinary catecholamine levels, and clinical response
M Donnelly, A J Zametkin, J L Rapoport, et al.
Psychopharmacology Bulletin
|
January 1, 1995
Pharmacologic profile of natural products used to treat psychotic illnesses
I W Chung, Y S Kim, J S Ahn, et al.
Archives of General Psychiatry
|
December 1, 1985
Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites
W Z Potter, M Scheinin, R N Golden, et al.
Life Sciences
|
September 3, 1984
The effect of desmethylimipramine on the metabolism of norepinephrine
A P Zavadil, R J Ross, H M Calil, et al.
Psychiatry Research
|
June 1, 1994
Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder
F X Castellanos, J Elia, M J Kruesi, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1975
Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites
J R Mitchell, U P Thorgeirsson, M Black, et al.
Psychopharmacology Bulletin
|
January 1, 1991
Signal transduction modulation by lithium: cell culture, cerebral microdialysis and human studies
H K Manji, J A Bitran, M I Masana, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 1, 1996
Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder
F X Castellanos, J Elia, M J Kruesi, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 167) with videos related to
Sort By:
Page
of 17
Clinical Pharmacology and Therapeutics
|
April 1, 1983
Effects of desmethylimipramine on plasma norepinephrine, pulse, and blood pressure
R J Ross, A P Zavadil, H M Calil, et al.
Archives of General Psychiatry
|
July 1, 1990
Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia
D Pickar, A Breier, J K Hsiao, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1986
Treatment of childhood hyperactivity with desipramine: plasma drug concentration, cardiovascular effects, plasma and urinary catecholamine levels, and clinical response
M Donnelly, A J Zametkin, J L Rapoport, et al.
Psychopharmacology Bulletin
|
January 1, 1995
Pharmacologic profile of natural products used to treat psychotic illnesses
I W Chung, Y S Kim, J S Ahn, et al.
Archives of General Psychiatry
|
December 1, 1985
Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites
W Z Potter, M Scheinin, R N Golden, et al.
Life Sciences
|
September 3, 1984
The effect of desmethylimipramine on the metabolism of norepinephrine
A P Zavadil, R J Ross, H M Calil, et al.
Psychiatry Research
|
June 1, 1994
Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder
F X Castellanos, J Elia, M J Kruesi, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1975
Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites
J R Mitchell, U P Thorgeirsson, M Black, et al.
Psychopharmacology Bulletin
|
January 1, 1991
Signal transduction modulation by lithium: cell culture, cerebral microdialysis and human studies
H K Manji, J A Bitran, M I Masana, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 1, 1996
Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder
F X Castellanos, J Elia, M J Kruesi, et al.
Page
of 17